Humacyte Inc (NASDAQ:HUMA) price closed lower on Monday, March 25, dropping -5.14% below its previous close.
A look at the daily price movement shows that the last close reads $3.31. The company’s 5Y monthly beta was ticking 1.52. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.60 and 52-week low of $1.96. The stock subtracted -27.48% on its value in the past month.
Humacyte Inc, which has a market valuation of $367.29 million, is expected to release its quarterly earnings report May 10, 2024 – May 14, 2024. Analysts tracking HUMA have forecast the quarterly EPS to shrink by -0.23 per share this quarter, while the same analysts predict the annual EPS to hit -$0.93 for the year 2024 and up to -$0.71 for 2025. In this case, analysts estimate an annual EPS growth of 13.10% for the year and 23.70% for the next year.
Staying with the analyst view, there is a consensus estimate of $2.9 million for the company’s annual revenue in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with 1 upward and no downward reviews. On the technical perspective front, indicators give HUMA a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that HUMA’s price is at present -12.30% off the SMA20 and -9.52% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 42.01, with weekly volatility standing at 7.13%. The indicator jumps to 7.86% when calculated based on the past 30 days. Humacyte Inc (NASDAQ:HUMA)’s beta value is holding at 1.47, while the average true range (ATR) indicator is currently reading 0.30.
An analysis of the Humacyte Inc (NASDAQ:HUMA) stock in terms of its daily trading volume indicates that the 3-month average is 884.08K.
Current records show that the company has 103.23M in outstanding shares. The insiders’ percentage holdings are 27.66% of outstanding shares while the percentage share held by institutions stands at 15.21%. But the 10.56% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
